Recombinant fusion protein comprising HIV gp120 linked to an enhancing CD4 binding site mAb
US-9951106-B2 · Apr 24, 2018 · US
Pazgier Marzena was listed as an assignee on 1 patent publication in 2018.
| Metric | Value |
|---|---|
| Company | Pazgier Marzena |
| Year | 2018 |
| Patents | 1 |
Representative publications for Pazgier Marzena in 2018.
Most common classification codes for Pazgier Marzena in 2018.
| CPC | Patents |
|---|---|
| A61K2039/505 | 1 |
| A61K39/12 | 1 |
| A61K39/21 | 1 |
| C07K14/005 | 1 |
| C07K14/162 | 1 |
Navigate to parent entity pages.